Pharmaceutical Substances Syntheses, Patents, Applications - Part 2 potx

Aceglutamide aluminum
A
I1
Aceglutamide aluminum
RN: 12607-92-0 MF: C35Hs9A13N,o024 MW: 1084.85
LD,,,: 460 mglkg (M, i.v.); 13.1
glkg
(M, p.0.);
400mglkg (R,i.v.);>14.5 g/kg(R,p.o.)
CN:
pentakis(~-acetyl-~-glutaminato)tetral~ydroxyirialuminum
ATC: A02AB; N06B
Use: peptic ulcer therapeutic
acetic anhydride L-glutamine
I
+
AI(OCH(CH,),),
+
aluminum isopropylate
Aceglutamide aluminum
I
DOS 2 127 176 (Kyowa Hakko; appl. 1.6.1971; J-prior. 5.6.1970).
US
3
787 466 (Kyowa Hakko; 22.1.1974; J-prior. 5.6.1970).
preparation
oj'Nz-acetyl-L-glutamine:
Reddy, A.V; Ravindranath,
B.:
Synth. Commun. (SYNCAV)
22

(2). 257 (1992).
Synge: Biochem.
J.
(BIJOAK) 33,673 (1939).
Fonnulation(s):
gran. 700 mg
Trade Nnme(s):
J:
Glumal
(Ky
owa Hakko)
Acemetacin
ATC:
MO~AB~~
Use:
non-steroidal
anti-inflammatory
RN: 53164-05-9 MF: C,lH,,CINO,
MW:
415.83 EINECS: 258-403-4
LDs,,: 55 mglkg (Mm, p.0.); 18.42mglkg
(Mf,
p.0.);
24.2 mglkg (Rm, p.0.); 30.1 mglkg
(Rf,
p.0.)
CN:
1
-(4-chlorobenzoyl)-5-methoxy-2-methyl-lH-indole-3-acetic
acid carboxymethyl ester

4-methomyaniline
4-methoxyphenylhydrazine
(I)
12
A Acemetacin
1.
NaOC2H5
2.
CI*O
H3CpCOOH
0
0
-
2.
benzyl chloroacetate
0 0
levulinic acid benzyl levulinoyloxyacetate
benzyl 12-(4-methoxyphenylhydrozano)-
'=?'
benzyl
(5-meVloxy-2-methyl-3-lndolyl-
4-chloro-
benzoyl chloride
benzyl
[I
-(4-chlorobenzoyl)-5-methoxy-
2-methyl-3-indolylocetoxy]acetate
(IV)
07
COOH

I
Acemetocin
indometacin
(4.
v.)
benzyl bromo-
acetate
Reference(s):
DOS 2 234 65 1 (Tropon; appl. 14.7.1972).
FR 2 192 828 (Tropon; appl. 13.7.1973; D-prior. 14.7.1972).
US 3 910 952 (Troponwerke Dinklage; 7.10.1975; appl. 28.6.1973; D-prior. 14.7.1972).
Acenocoumarol
A
13
preparation of
4-methoxyphenylhydrazine
from
4-methoxyaniline b-anisidine):
Lee, A R. et al.: J. Heterocycl. Chem. (JHTCAD)
32
(I), 1-12 (1995).
Clade, D.W. et al.: J. Chem. Soc., Perkin Trans. 2 (JCPKBH)
,
909-916 (1982).
DE 70 459 (Riedel; 12.1 1.1891).
Altschul: Ber. Dtsch. Chem. Ges. (BDCGAS)
25,
1849 (1892).
preparation of
benzyl levulinoyloxyacetate:

Boltze,
K H.;
Brendler, 0.; Jacobi, H.; Opitz, W.; Raddatz, S. et al.: Arzneim Forsch. (ARZNAD)
30
@a), 1314-
1325 (1980).
~ormulati&(s):
cps. 30 mg, 60 mg; s. r. cps. 90 mg
Trade Name(s):
D: Rantudil (Bayer; 1980)
I:
Acemix (Bioprogress) J: Rantudil (Kowa; 1984)
GB: Emflex (Merck) Solar (Bioindustria)
Acenocoumarol
(Acenocumarin; Nicoumalone)
ATC: BOlAA07
Use: anticoagulant
RN: 152-72-7 MF: C,9H,5N06 MW: 353.33 EINECS: 205-807-3
LD,,: 115 mg/kg(M,i.p.); 1470mg/kg(M,p.o.);
513 mglkg (R, p.0.)
CN:
4-hydroxy-3-[l-(4-nitrophenyl)-3-oxobutyl]-2H-l-benzopyran-2-one
methyl acetic anhydride
salicylote
(wintergreen oil)
methyl ocetyl-
solicylote
OH
4-hydroxy-
coumorin

(I)
,
+
pN02
-
C",
0
4-nitro-
benzolocetone
Acenocournorol
US 2 648 862 (Geigy; 1953; CH-prior. 1950).
Formulation(s):
tabl. 1 mg, 4 mg
Trade Name(s):
D:
Sintrom (Geigy); wfm
GB: Sinthrome (Geigy) J:
Sintrom (Ciba-Geigy)
F:
Sintrom (Novartis)
I:
Sintrom (Novartis) USA:
Sintrom (Geigy); wfm
14
A
Acepromazine
Acepromazine
ATC: N05AA04
Use: neuroleptic, anti-emetic, tranquilizer
RN:

61-00-7 MF: C,,H22N20S MW. 326.46 EINECS: 200-496-0
LD,,,: 59 mgkg (M, i.v.)
CN:
1-[I0-[3-(dimethylamino)propyl]-I0H-phenothiazin-2-yl]ethanone
maleate
(1:l)
RN: 3598-37-6 MF: CLyHZ2N2OS
,
C,H,O, MW: 442.54 EINECS: 222-748-9
LD,,,: 65 mgkg (M, i.v.);
95 mglkg (R, i.v.); 400 mgtkg (R, p.0.)
2-ocetylphenothiazine 3-dimethylomino- Acepromozine
prapyl chloride
Reference(s):
DE 1 049 865 (Bayer; appl. 7.9.1955).
Schmitt,
J.
et al.: Bull. Soc. Chim.
Fr.
(BSCFAS) 1957,938, 1474.
Formulation(s):
drops 1 mg/lO drops; syrup 2.5 mg; tabl. 10 mg (as maleate)
Trade Narne(s):
F: Noctran (Menarini)-comb.
J:
Plebal (Fujinaga-Sankyo)-
comb.
Aceprometazine
ATC: NOSAA
Use: neuroleptic, antitussive

RN: 13461-01-3 MF: C,yH22N20S MW: 326.46 EINECS: 236-661-9
LD,,: 517 mgkg (M, p.0.)
CN:
1-[l0-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl]ethanone
maleate
RN: 7455-18-7 MF: C,,H,N,OS. C,H,O, MW: 442.54
2-a~et~lphenothiozine 2-dimethylomino- Aceprometozine
propyl chloride
Reference(s):
DE 1 049 865 (Bayer; appl. 7.9.1955).
Formulation(s):
tabl. 13.55 mg (as maleate in combination with 400 mg meprobramate)
Acetarsol
A
15
Trade Nume(s):
D: Clindorm (Midy)-comb. Noctran (Menarini)-comb.
F:
MCpronizine (Sanofi)- J: Noctran (Clin-Midy-
comb. Sanofi); wfm
Acetarsol
(Acetarsone)
ATC: A07AX02; GO 1ABOI; POlCD02
Use: antiprotozoal (trichomonas)
RN: 97-44-9
MF:
C,H,,,AsNO, MW: 275.09 EINECS: 202-582-3
LD,,,:
180 mglkg
(M,

i.v.);
4
mglkg
(M,
p.0.)
CN:
[3-(acety1amino)-4-hydroxyphenyl]arsonic
acid
monosodium
salt
RN: 5892-48-8 MF: C,H,AsNNaO,
MW:
297.07 EINECS: 227-573-1
sodium
CI CI
orsenite
4-chloro-
4-chlorobenzene-
4-chlorophenyl- 4-chloro-3-nitro-
aniline
diazonium chloride
arsonic acid phenylarsonic acid
(I)
R
0
I I
~oOH(33%), 100°C
HO-As-OH
No,S,04 or Fe-NaOH
HO-As-OH

1
+
8-
sodium
NO2
dithionite
OH
@
OH
NH2
4-hydroxy-3-nitro- 3-amino-4-hydroxy-
phenylarsonic acid phenylarsanic acid
(11)
Refermce(s):
Raiziss, G.W.; Gavron, J.L.:
J.
Am. Chem. Soc. (JACSAT)
43,
583 (1921).
Raiziss, G.W.; Fisher, B.C.:
J.
Am. Chem. Soc. (JACSAT)
48,
1323 (1926).
DRP 250
264
(H. Bart; appl.
1910).
DRP 245 536 (Hoechst; appl. 191 1).
DRP 224 953 (Hoechst; appl. 1909).

Formulution(s):
collutorium (mouth wash) 0.5 mg1100
g
Trade Name(s):
F: Arpha collutoire Gynoplix (Doms-Adrian); Humcx collutoire
(Fournier)-comb.; wfm wfm
(Fournier)-comb.; wfm
Collargent ac6tarsol
Gynoplix (ThCrap1ix)- Humex Fournier collutoire
(Sarbach)-comb.; wfm comb.; wfm
(Fournier)-comb.; wfm
16
A
Acetazolamide
Polygynax (1nnothCra)- Sanogyl (Pharmascience)-
I:
Gynoplix (Vaillant)
comb.; wfm comb.; wfm J: Neo Osvarsan (Banyu)
Polygynax Virgo Sanogyl (Vilette); wfm Osvarsan (Banyu)
(1nnothCra)-comb.; wfm GB: Pyorex (Bengue)-comb.;
Pyorex (Bailly-Speab)- wfm
comb.; wfm
S.
V.
C. (May
&
Baker)
Acetazolamide
(Acetazoleamide)
ATC: SOlECOl

Use: diuretic
RN: 59-66-5
MF:
C4H6N,03S2
MW:
222.25 EINECS: 200-440-5
LD,,: 1175 mgkg
(M,
i.p.1; >3000 mglkg
(M,
i.v.1; 4300 mgkg (M, p.0.); >3000 mg/kg
(M,
s.c.);
2750 mgkg
(R,
i.p.);
>I 500mg/kg (g. p., LC.)
>2000 mglkg (dog, i.v.);
CN:
N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
ommonium hydrozine hydrozine-
1,2-bis-
2-amino-5-mercopto-
rhodanide (thiacorboxamide) 1,3,4-thiodiozole
(1)
H
H
o
o
H,C~N~S~SO,-CI

I
+
-+
H~CYN-C~Y~H
c&
H3C
0
CH3
0
N-N
0
N-N
acetic anhydride 2-acetylornino-5- 2-ocetylomino-1,3,4-
mercapta-1.3.4- thiadiozole-5-sulfonyl
thiadiazole chloride (11)
I
Acetazolamide
I
Reference(s):
US 2 554 816 (American Cyanamid; 1951; prior. 1950).
Roblin, R.O.; Clapp, J.W.: J. Am. Chem. Soc. (JACSAT) 72,4890
(1
950).
similar process:
US 2 980 679 (Omikron-Gagliardi; 18.4.1961; I-prior. 4.4.1957).
Formularion(s):
amp. 500 mg; cream 10
9%;
lyo. 500 mg; powder 500 mg;
s.

r. cps. 500 mg; tabl. 125 mg,
250 mg
Trade Name(s):
D: Diamox (Lederle) Diamox Sustets (Lederle); Diamox S. R. (Lederle-
Diuramid (medpharm) wfm
Takeda)
Glaupax (CIBA Vision) I:
Diamox (Cyanamid) Didoc (Sawai)
F:
DCfiltran (Labs. Jumer) J: Acetamox (Santen)
Donmox (Hotta)
Diamox
(ThCraplix)
Atenezol (Tsuruhara) Zohnox (Konto)
GB: Diamox (Storz)
Diamox (Lederle-Takeda) USA: Diamox (Lederle)
Acetiamine
A
17
Acetiamine
ATC: All
Use: vithin B,-derivative, neurotropic
analgesic
RN: 299-89-8 MF:
C,,H2,N404S MW: 366.44
CN: ethanethioic acid
S-[l-[2-(acetyloxy)ethyll-2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-
1-propenyl] ester
thiamine
(1)

(9.
v.)
Acetiamine
I
Reference
(s):
US 2 752 348 (Takeda; 1956; J-prior. 1952).
Matsukawa,
T.;
Kawasaki,
H.:
Yakugaku Zasshi (YKKZAJ)
23,
705 (1953).
Gauthier, B. et al.: Ann. Pharm. Fr. (APFRAD) 21,655 (1963).
Formulation(s):
drg. 50 mg
Trade Name(s):
D: Thianeurone (RhBne-
F:
Algo-Ntvriton (Pharmuka);
Poulenc); wfm wfm
Acetohexamide
(Cyclamide)
ATC: AlOBB31
Use: antidiabetic
RN: 968-81-0 MF: C,,H20N204S MW: 324.40 EINECS: 213-530-4
LD,,,: >2500 mglkg (M, p.o.);
Wkg
(R,

p.0.)
CN:
4-acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfonamide
4-amino-
acetaphenone
4-acetylphenyl- 4-acetylbenzene-
sulfonyl chloride sulfonomide
(1)
18
A
Acetophenazine
1.
K,CO,, ocetone
3.
aq. HCI
I
_____*
2. cyclohexyl
isocyanate
0
Acetohexamide
Reference(s):
US 3 320 312 (Lilly; 16.5.1967; prior. 28.4.1960).
DE
1
177 631 (Lilly; appl. 21.4.1961; USA-prior. 28.4.1960).
DE 1 135 891 (Hoechst; appl. 30.6.1960).
Forrnulation(s):
tabl.
250 mg, 500 mg

Trade Name(s):
GB: Dimelor (Lilly); wfm
J:
Dimelin (Shionogi)
I:
Dimelor (Lilly); wfm USA: Dymelor (Lilly)
Acetophenazine
ATC: N05AB07
Use: neuroleptic, antipsychotic
RN: 2751-68-0
MF:
C,,H,,N,O,S
MW:
411.57
CN:
1-[10-[3-[4-(2-hydroxyethyl)-l-piperaziny1]propyl]-l0H-phenothiazin-2-yl]ethanone
maleate
(1:2)
RN: 5714-00-1 MF: C,,H,9N,0,S. 2C4H404
MW:
643.71 EINECS: 227-202-3
LD,o: 71 mglkg (M, i.v.);
60 mgkg
(R,
i.p.); 39 mglkg (R, i.v.); 415 mglkg (R, p.0.)
chloropropane
2-acetylphenothiazine 2-acetyl-10-(3-chloro-
propyl)phenothiozine
(I)
1

-(2-hydroxyethy1)-
piperazine
Acetophenazine
I
Reference(s):
US 2 985 654 (Schering Corp.; 23.5.1961; prior. 21.9.1956).
Formularion(s):
tabl. 20 mg (as dimaleate)
Trade Name(s):
USA: Tindal (Schering); wfm
Acetorphan
A
19
Acetorphan
(Racecadotril)
ATC:
A07XA04
Use: antisecretory, enkephalinaseinhibitor
RN:
81 110-73-8
MF:
C2,H,,NO4S
MW:
385.48
CN:
(f)-N-[2-[(Acetylthio)methyl]-1-oxo-3-phenylpropyl]glycine
phenylmethyl ester
0
.
AcO,

0 0
OHCyJ
+
0 0
toluene
___,
H3CfiOIU10nCH3
piperidine
benzaldehyde
diethyl
rnalanate
diethyl
benzylidenernalonate
(1)
1.
HZ,
Pd-C
HOOC COOH
Y
H2C COOH
2.
NoOH.
H20
(CH20),
.
Et,NH
Y'
I
-
-

poraforrnoldehyde,
diethylornine
benzylrnolonic
acid
2-benzylacrylic
acid
(11)
thioocetic
ocid
(+)-2-acetylthiornethyl-
3-phenylpropionic
acid
(111)
TEA,
DCC,
HOBt,
0a
TOS-OH
TYI/CHCI~
111
+
H~N-
A
0
glycine
benzyl
ester tosylate
Acetorphan
EP
38 758 (Roques,

B.
et
al.;
appl. 17.4.1981;
F-prior.
17.4.1980).
EP
729 936 (Soc. Civile Bioprojet; appl. 1.3.1996;
F-prior.
3.3.1995).
synthesis of
Ill:
Mannich,
C.;
Ritsert,
K.:
Ber. Dtsch. Chem. Ges. (BDCGAS)
57,
11 16 (1924).
Formidation(s):
cps.
100
mg
Trade Name(s):
F:
Tiorfan (Bioprojet; 1993)
20
A
Acetrizoic acid
Acetrizoic acid

ATC: V08AA07
Use: X-ray contrast medium
RN: 85-36-9 MF:
CyH613N03 MW: 556.86 EINECS: 201-600-7
LD,,,: 8000 mgkg (M, i.v.); 20 g/kg (M, p.0.)
CN:
3-(acety1amino)-2,4,6-triiodobenzoic
acid
meglumine salt
(1:l)
RN: 22154-43-4 MF: CyH,13N03. C,H,,NO, MW: 752.08
LD,: 10.1 g/kg (M, i.v.)
sodium salt
RN: 129-63-5 MF: CyH,13NNa0, MW: 578.85 EINECS: 204-956-1
LD,,: 12156 mg/kg (M, i.m.); 7800 mgkg (M, i.v.);
6400 mgkg
(R,
i.v.);
5200 mgkg (rabbit, i.v.);
5600 mgkg (cat, i.v.);
6300 mgkg (dog, i.v)
COOH
HN03.H2S04
Fe,
CH3COOH
ICI
ZH
.a
NH2
chloride

1
benzoic 3-nitrobenzoic 3-ominobenzoic
ocid acid
ocid
3-omino-2,4.6-
triiadobenzoic
ocid
(I)
I
Acetrizoic acid
US 2 61 1 786 (Mallinckrodt; 1952; appl. 1950; prior. 21.7.1948).
Wallingford et
al.:
J. Am. Chem. Soc. (JACSAT) 74,4365 (1952).
3-amino-2,4,6-triiodobenzoic
acid:
Kretzer: Ber. Dtsch. Chem. Ges: (BDCGAS)
30,
1944 (1 897).
Formulation(s):
vial. 250 mglml, 500 mglml
Trade Name(s):
F: Vasurix (Guerbet); wfm
J:
Diaginol (Banyu); wfm Py elokon-R
GB: Diaginol (May
&
Baker); USA: Cystocon (Mallinckrodt); (Mallinckrodt); wfm
wfm wfm Salpix (Ortho); wfm
Acetylcholine chloride

ATC: SOlEB09
Use: parasympathomimetic, miotic,
vasodilator (peripheral)
RN: 60-31-1 MF:
C7H,,C1N0, MW: 181.66 EINECS: 200-468-8
LD,,,:
lOmg/kg(M,i.v.);3gkg(M,p.o.);
22 mgkg
(R,
i.v.); 2500 mglkg (R, p.0.)
CN:
2-(acety1oxy)-N,N,N-trimethylethanaminium
chloride